Synthetic heparin-binding growth factor analogs (United States Patent 7,166,574)
Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof (United States Patent 7,129,224)
Mutant human factor IX with an increased resistance to inhibition by heparin (United States Patent 7,125,841)
Combination treatment with t-PA variant and low molecular weight heparin (United States Patent 7,084,118)
Methods of coating a device using anti-thrombin heparin (United States Patent 7,045,585)
Diagnostic assay for type 2 heparin-induced thrombocytopenia (United States Patent 7,011,953)
Process for prophylaxis and therapy of thrombotic processes employing heparin having particular average molecular weights (United States Patent 7,008,933)
Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing the same (United States Patent 7,005,415)
Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them (United States Patent 6,969,705)
Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis (United States Patent 6,964,854)
Heparin compositions and methods of making and using the same (United States Patent 6,953,625)
Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin (United States Patent 6,949,345)
Method to produce a solid form of heparin (United States Patent 6,933,372)
Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans (United States Patent 6,855,801)
Solid- and solution-phase synthesis of heparin and other glycosaminoglycans (United States Patent 6,846,917)
Anti-heparin peptides (United States Patent 6,835,808)
Process for producing desulfated polysaccharide, and desulfated heparin (United States Patent 6,809,086)
Inhibition of L-selectin and P-selectin mediated binding using heparin (United States Patent 6,787,365)
Method of treating heparin-induced thrombocytopenia (United States Patent 6,743,426)
Method and device for determining the concentration of heparin in a sample of fluid (United States Patent 6,731,379)
Controlled release of non heparin-binding growth factors from heparin-containing matrices (United States Patent 6,723,344)
Low molecular weight heparin assay, system and reagent therefor (United States Patent 6,680,177)
Method and device for determining the concentration of heparin in a sample of fluid (United States Patent 6,630,989)
Silyl and Heparin compositions (United States Patent 6,630,580)
Heparin compositions and methods of making and using the same (United States Patent 6,630,460)
Heparin delivery method (United States Patent 6,605,114)
Inhibition of L-selectin and P-selection mediated binding using heparin (United States Patent 6,596,705)
Plaster for topical use containing heparin and diclofenac (United States Patent 6,592,891)
Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption (United States Patent 6,589,943)
Low-molecular heparin modification and remedy for skin ulcer (United States Patent 6,569,840)
Composition comprising heparin as a non-thrombogenic surface coating agent (United States Patent 6,559,132)
Process for producing desulfated polysaccharide, and desulfated heparin (United States Patent 6,545,136)
Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof (United States Patent 6,518,244)
Heparin binding neurotrophic factor gene sequence (United States Patent 6,511,823)
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin (United States Patent 6,458,383)
DNA encoding heparin-binding growth factor (United States Patent 6,448,381)
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor (United States Patent 6,387,878)
Heparin compositions of very low molecular weight (United States Patent 6,384,021)
Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders (United States Patent 6,346,517)
Heparin derivatives and process for the preparation thereof (United States Patent 6,326,476)
ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin (United States Patent 6,306,165)
Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin (United States Patent 6,291,439)
Peptides derived from the heparin binding domain of fibronectin (United States Patent 6,274,704)
Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin (United States Patent 6,258,798)
Heparin binding mitogen with homology to epidermal growth factor (EGF) (United States Patent 6,235,884)
Method of treating interstitial cytitis with recombinant heparin-binding epidermal growth factor-like growth factor (HB-EGF) (United States Patent 6,232,289)
Process for the production of heparin (United States Patent 6,232,093)
Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus (United States Patent 6,207,653)
Heparin binding peptides (United States Patent 6,200,955)
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor (United States Patent 6,191,109)
Vascular graft impregnated with a heparin-containing collagen sealant (United States Patent 6,162,247)
Heparin binding--epidermal growth factor-like growth factor in the diagnosis of Interstitial Cystitis (United States Patent 6,156,522)
Heparin derivatives for treatment of angina pectoris (United States Patent 6,150,342)
Process for producing desulfated polysaccharide, and desulfated heparin (United States Patent 6,140,481)
Method of determining the heparin content (United States Patent 6,140,062)
Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist (United States Patent 6,136,794)
Heparin derivatives having antimetastatic activity (United States Patent 6,130,210)
Method of synthesis of desulfated heparin and use thereof for inhibition of elastase and cathepsin (United States Patent 6,077,683)
Modified low molecular weight heparin that inhibits clot associated coagulation factors (United States Patent 6,075,013)
Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof (United States Patent 6,051,549)
Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique (United States Patent 6,010,911)
Methods of treating asthma with o-desulfated heparin (United States Patent 5,990,097)
Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin (United States Patent 5,976,534)
Method for promoting angiogenesis using heparin and adenosine (United States Patent 5,972,903)
Method of detecting heparin-induced thrombocytopenia (United States Patent 5,972,718)
Method and kit for detecting heparin induced thrombocytopenia (United States Patent 5,972,717)
Heparin-independent, high sensitivity platelet function evaluation technique (United States Patent 5,972,712)
Flow cytometry assay for heparin-induced thrombocytopenia (United States Patent 5,939,276)
Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications (United States Patent 5,922,358)
Peptides for heparin and low molecular weight heparin anticoagulation reversal (United States Patent 5,919,761)
Method of synthesis of desulfated heparin and use thereof for inhibition of elastase and cathespin (United States Patent 5,912,237)
Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate (United States Patent 5,902,798)
Method for actively binding heparin to crosslinked biological tissues (United States Patent 5,891,196)
Heparin-binding peptides (United States Patent 5,877,153)
Heparin-binding growth factor (HBGF) polypeptides (United States Patent 5,876,730)
Stent and method of varying amounts of heparin coated thereon to control treatment (United States Patent 5,876,433)
Heparin-like derivatives (United States Patent 5,872,110)
Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin (United States Patent 5,855,618)
Vascular graft with a heparin-containing collagen sealant (United States Patent 5,851,230)
Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof (United States Patent 5,849,721)
Fanphiregulins: a family of heparin-binding epithelial cell growth factors (United States Patent 5,830,995)
Heparin-binding proteins (United States Patent 5,814,602)
Heparin binding mitogen with homology to epidermal growth factor (EGF) (United States Patent 5,811,393)
Method for controlling O-desulfation of heparin (United States Patent 5,808,021)
Affinity purified heparin (United States Patent 5,807,982)
Device and process for the biospecific removal of heparin (United States Patent 5,801,063)
Therapeutic methods of using O-desulfated heparin derivatives (United States Patent 5,795,875)
System for assaying binding to a heparin-binding growth factor receptor (United States Patent 5,789,182)
Sulfated glycosaminoglycanoid derivatives of the heparin sulfate type (United States Patent 5,773,605)
Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof (United States Patent 5,770,563)
Heparin derivatives having antimetastatic activity (United States Patent 5,763,421)
Flow cytometry assay for heparin-induced thrombocytopenia (United States Patent 5,763,201)
Test for the detection of anti-heparin antibodies (United States Patent 5,753,445)
Process for preparing covalently bound-heparin containing polyurethane-peo-heparin coating compositions (United States Patent 5,741,881)
Sulfated maltooligosaccharides with heparin-like properties (United States Patent 5,739,115)
Peptides for heparin and low molecular weight heparin anticoagulation reversal (United States Patent 5,721,212)
Method of attaching heparin to, and immobilizing it on, inorganic substrate surfaces of cardiovascular implants (United States Patent 5,718,726)
Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters (United States Patent 5,714,477)
Use of lactoferrin to modulate and/or neutralize heparin activity (United States Patent 5,712,247)
Process for anticoagulation during extracorporeal blood circulation sequentially using citrate or nafamostat and heparin (United States Patent 5,709,993)
Synthetic heparin-binding growth factor analogs (United States Patent 7,166,574)
Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof (United States Patent 7,129,224)
Mutant human factor IX with an increased resistance to inhibition by heparin (United States Patent 7,125,841)
Combination treatment with t-PA variant and low molecular weight heparin (United States Patent 7,084,118)
Methods of coating a device using anti-thrombin heparin (United States Patent 7,045,585)
Diagnostic assay for type 2 heparin-induced thrombocytopenia (United States Patent 7,011,953)
Process for prophylaxis and therapy of thrombotic processes employing heparin having particular average molecular weights (United States Patent 7,008,933)
Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing the same (United States Patent 7,005,415)
Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them (United States Patent 6,969,705)
Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis (United States Patent 6,964,854)
Heparin compositions and methods of making and using the same (United States Patent 6,953,625)
Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin (United States Patent 6,949,345)
Method to produce a solid form of heparin (United States Patent 6,933,372)
Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans (United States Patent 6,855,801)
Solid- and solution-phase synthesis of heparin and other glycosaminoglycans (United States Patent 6,846,917)
Anti-heparin peptides (United States Patent 6,835,808)
Process for producing desulfated polysaccharide, and desulfated heparin (United States Patent 6,809,086)
Inhibition of L-selectin and P-selectin mediated binding using heparin (United States Patent 6,787,365)
Method of treating heparin-induced thrombocytopenia (United States Patent 6,743,426)
Method and device for determining the concentration of heparin in a sample of fluid (United States Patent 6,731,379)
Controlled release of non heparin-binding growth factors from heparin-containing matrices (United States Patent 6,723,344)
Low molecular weight heparin assay, system and reagent therefor (United States Patent 6,680,177)
Method and device for determining the concentration of heparin in a sample of fluid (United States Patent 6,630,989)
Silyl and Heparin compositions (United States Patent 6,630,580)
Heparin compositions and methods of making and using the same (United States Patent 6,630,460)
Heparin delivery method (United States Patent 6,605,114)
Inhibition of L-selectin and P-selection mediated binding using heparin (United States Patent 6,596,705)
Plaster for topical use containing heparin and diclofenac (United States Patent 6,592,891)
Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption (United States Patent 6,589,943)
Low-molecular heparin modification and remedy for skin ulcer (United States Patent 6,569,840)
Composition comprising heparin as a non-thrombogenic surface coating agent (United States Patent 6,559,132)
Process for producing desulfated polysaccharide, and desulfated heparin (United States Patent 6,545,136)
Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof (United States Patent 6,518,244)
Heparin binding neurotrophic factor gene sequence (United States Patent 6,511,823)
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin (United States Patent 6,458,383)
DNA encoding heparin-binding growth factor (United States Patent 6,448,381)
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor (United States Patent 6,387,878)
Heparin compositions of very low molecular weight (United States Patent 6,384,021)
Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders (United States Patent 6,346,517)
Heparin derivatives and process for the preparation thereof (United States Patent 6,326,476)
ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin (United States Patent 6,306,165)
Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin (United States Patent 6,291,439)
Peptides derived from the heparin binding domain of fibronectin (United States Patent 6,274,704)
Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin (United States Patent 6,258,798)
Heparin binding mitogen with homology to epidermal growth factor (EGF) (United States Patent 6,235,884)
Method of treating interstitial cytitis with recombinant heparin-binding epidermal growth factor-like growth factor (HB-EGF) (United States Patent 6,232,289)
Process for the production of heparin (United States Patent 6,232,093)
Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus (United States Patent 6,207,653)
Heparin binding peptides (United States Patent 6,200,955)
Methods of treating intestinal ischemia using heparin-binding epidermal growth factor (United States Patent 6,191,109)
Vascular graft impregnated with a heparin-containing collagen sealant (United States Patent 6,162,247)
Heparin binding--epidermal growth factor-like growth factor in the diagnosis of Interstitial Cystitis (United States Patent 6,156,522)
Heparin derivatives for treatment of angina pectoris (United States Patent 6,150,342)
Process for producing desulfated polysaccharide, and desulfated heparin (United States Patent 6,140,481)
Method of determining the heparin content (United States Patent 6,140,062)
Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist (United States Patent 6,136,794)
Heparin derivatives having antimetastatic activity (United States Patent 6,130,210)
Method of synthesis of desulfated heparin and use thereof for inhibition of elastase and cathepsin (United States Patent 6,077,683)
Modified low molecular weight heparin that inhibits clot associated coagulation factors (United States Patent 6,075,013)
Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof (United States Patent 6,051,549)
Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique (United States Patent 6,010,911)
Methods of treating asthma with o-desulfated heparin (United States Patent 5,990,097)
Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin (United States Patent 5,976,534)
Method for promoting angiogenesis using heparin and adenosine (United States Patent 5,972,903)
Method of detecting heparin-induced thrombocytopenia (United States Patent 5,972,718)
Method and kit for detecting heparin induced thrombocytopenia (United States Patent 5,972,717)
Heparin-independent, high sensitivity platelet function evaluation technique (United States Patent 5,972,712)
Flow cytometry assay for heparin-induced thrombocytopenia (United States Patent 5,939,276)
Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications (United States Patent 5,922,358)
Peptides for heparin and low molecular weight heparin anticoagulation reversal (United States Patent 5,919,761)
Method of synthesis of desulfated heparin and use thereof for inhibition of elastase and cathespin (United States Patent 5,912,237)
Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate (United States Patent 5,902,798)
Method for actively binding heparin to crosslinked biological tissues (United States Patent 5,891,196)
Heparin-binding peptides (United States Patent 5,877,153)
Heparin-binding growth factor (HBGF) polypeptides (United States Patent 5,876,730)
Stent and method of varying amounts of heparin coated thereon to control treatment (United States Patent 5,876,433)
Heparin-like derivatives (United States Patent 5,872,110)
Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin (United States Patent 5,855,618)
Vascular graft with a heparin-containing collagen sealant (United States Patent 5,851,230)
Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof (United States Patent 5,849,721)
Fanphiregulins: a family of heparin-binding epithelial cell growth factors (United States Patent 5,830,995)
Heparin-binding proteins (United States Patent 5,814,602)
Heparin binding mitogen with homology to epidermal growth factor (EGF) (United States Patent 5,811,393)
Method for controlling O-desulfation of heparin (United States Patent 5,808,021)
Affinity purified heparin (United States Patent 5,807,982)
Device and process for the biospecific removal of heparin (United States Patent 5,801,063)
Therapeutic methods of using O-desulfated heparin derivatives (United States Patent 5,795,875)
System for assaying binding to a heparin-binding growth factor receptor (United States Patent 5,789,182)
Sulfated glycosaminoglycanoid derivatives of the heparin sulfate type (United States Patent 5,773,605)
Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof (United States Patent 5,770,563)
Heparin derivatives having antimetastatic activity (United States Patent 5,763,421)
Flow cytometry assay for heparin-induced thrombocytopenia (United States Patent 5,763,201)
Test for the detection of anti-heparin antibodies (United States Patent 5,753,445)
Process for preparing covalently bound-heparin containing polyurethane-peo-heparin coating compositions (United States Patent 5,741,881)
Sulfated maltooligosaccharides with heparin-like properties (United States Patent 5,739,115)
Peptides for heparin and low molecular weight heparin anticoagulation reversal (United States Patent 5,721,212)
Method of attaching heparin to, and immobilizing it on, inorganic substrate surfaces of cardiovascular implants (United States Patent 5,718,726)
Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters (United States Patent 5,714,477)
Use of lactoferrin to modulate and/or neutralize heparin activity (United States Patent 5,712,247)
Process for anticoagulation during extracorporeal blood circulation sequentially using citrate or nafamostat and heparin (United States Patent 5,709,993)